English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Monday, April 27, 2026
Press Releases for Thursday, April 16, 2026
Mitani Sangyo Filed U.S. Patent Application for AI Reliability Governance Framework
23:00 HKT/SGT
Datavault AI 於紐約和費城啟用首批邊緣 GPU 據點;價值 14.4 億至 19.2 億美元的量子就緒機隊,預計將於 2026 年底前覆蓋全美 100 多個城市
21:50 HKT/SGT
Datavault AI在纽约和费城的首批边缘GPU站点正式投入运营;价值14.4亿至19.2亿美元的抗量子计算集群将于2026年底前覆盖全美100多个城市
21:50 HKT/SGT
Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
21:50 HKT/SGT
TANAKA PRECIOUS METAL NEXT Certified as a Special Subsidiary
20:00 HKT/SGT
InnoEX and Electronics Fair (Spring Edition) attract over 88,000 global buyers
19:58 HKT/SGT
Focus Graphite Appoints Former Chief of the Defence Staff General Wayne Eyre to Advisory Board
17:58 HKT/SGT
核心产品潜力十足多管线商业化落地 迈威生物赴港上市打开成长空间
15:52 HKT/SGT
核心產品潛力十足多管線商業化落地 邁威生物赴港上市打開成長空間
15:52 HKT/SGT
Isuzu and Toyota to Jointly Develop Japan's First Mass-produced Light-duty Fuel Cell Electric Truck
14:53 HKT/SGT
Honda to Begin Sales of All-new Insight EV
14:31 HKT/SGT
3 Years and 11 Months! 'AI+All-in-One PV Storage' Sigenergy Listed on HKEX: Fastest IPO Record for a Chinese Enterprise
11:31 HKT/SGT
3年11月!「AI+光儲一體化第一股」思格新能源刷新中國企業港股IPO最快紀錄 獲淡馬錫、高瓴等「全明星」資本加持
11:31 HKT/SGT
Honda、新型乗用EV「INSIGHT」を発売
11:00 HKT/SGT
OBI Pharma、AACR 2026年次総会で10件のポスター発表を開催
08:00 HKT/SGT
OBI Pharma 宣布將在 2026 年 AACR 年會上展示十篇海報,內容涵蓋 GlycOBI(R) 基於糖鏈的位點特異性抗體藥物偶聯物(ADC):單特異性與雙特異性(包括雙載荷)以及 Obrion(TM) ADC 賦能技術
07:00 HKT/SGT
OBI Pharma 宣布将在 2026 年 AACR 年会上展示十篇海报,内容涵盖 GlycOBI(R) 基于糖链的位点特异性抗体药物偶联物(ADC):单特异性与双特异性(包括双载荷)以及 Obrion(TM) ADC 赋能技术
07:00 HKT/SGT
ACN Search:
Asian Financial Forum kicks off 2026 as region's first major event of 2026
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575